Analgesia and sedation in patients with ARDS
Abstract Acute Respiratory Distress Syndrome (ARDS) is one of the most demanding
conditions in an Intensive Care Unit (ICU). Management of analgesia and sedation in ARDS …
conditions in an Intensive Care Unit (ICU). Management of analgesia and sedation in ARDS …
Sedation, analgesia, and paralysis in COVID-19 patients in the setting of drug shortages
MA Ammar, GL Sacha, SC Welch… - Journal of intensive …, 2021 - journals.sagepub.com
The rapid spread of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
has led to a global pandemic. The 2019 coronavirus disease (COVID-19) presents with a …
has led to a global pandemic. The 2019 coronavirus disease (COVID-19) presents with a …
[HTML][HTML] Diagnosis and treatment of acute pulmonary inflammation in critically ill patients: the role of inflammatory biomarkers
S Chalmers, A Khawaja, PM Wieruszewski… - World journal of …, 2019 - ncbi.nlm.nih.gov
Pneumonia and acute respiratory distress syndrome are common and important causes of
respiratory failure in the intensive care unit with a significant impact on morbidity, mortality …
respiratory failure in the intensive care unit with a significant impact on morbidity, mortality …
Inhalational volatile-based sedation for COVID-19 pneumonia and ARDS
Hospitals worldwide are experiencing a shortage in essential intravenous sedative
medications. This is attributable to high number and high sedative needs of COVID-19 …
medications. This is attributable to high number and high sedative needs of COVID-19 …
[HTML][HTML] Sedation and neuromuscular blocking agents in acute respiratory distress syndrome
J Bourenne, S Hraiech, A Roch… - Annals of …, 2017 - ncbi.nlm.nih.gov
Mechanical ventilation (MV) is the cornerstone of acute respiratory distress syndrome
(ARDS) management. The use of protective ventilation is a priority in this acute phase of …
(ARDS) management. The use of protective ventilation is a priority in this acute phase of …
Comparison of isoflurane and propofol sedation in critically ill COVID-19 patients—a retrospective chart review
A Kermad, J Speltz, G Danziger, T Mertke, R Bals… - Journal of …, 2021 - Springer
Purpose In this retrospective study, we compared inhaled sedation with isoflurane to
intravenous propofol in invasively ventilated COVID-19 patients with ARDS (Acute …
intravenous propofol in invasively ventilated COVID-19 patients with ARDS (Acute …
Inhaled sedation in the intensive care unit
M Jabaudon, R Zhai, R Blondonnet… - Anaesthesia Critical Care …, 2022 - Elsevier
Inhaled sedation with halogenated agents, such as isoflurane or sevoflurane, is now
feasible in intensive care unit (ICU) patients through dedicated vaporisers and scavenging …
feasible in intensive care unit (ICU) patients through dedicated vaporisers and scavenging …
Lung-protective sedation: moving toward a new paradigm of precision sedation
EB Kassis, JR Beitler, D Talmor - Intensive Care Medicine, 2023 - Springer
Lung-protective ventilation (LPV) has primarily focused on limiting lung injury (VILI)
secondary to overdistension and collapse [1]. Deep sedation is often required for tolerance …
secondary to overdistension and collapse [1]. Deep sedation is often required for tolerance …
Inhaled sedation for invasively ventilated COVID-19 patients: a systematic review
G Landoni, O Belloni, G Russo, A Bonaccorso… - Journal of Clinical …, 2022 - mdpi.com
Background: Volatile anesthetics were used as sedative agents in COVID-19 (Coronavirus
Disease 2019) invasively ventilated patients for their potentially beneficial pharmacological …
Disease 2019) invasively ventilated patients for their potentially beneficial pharmacological …
Towards a biological definition of ARDS: are treatable traits the solution?
The pathophysiology of acute respiratory distress syndrome (ARDS) includes the
accumulation of protein-rich pulmonary edema in the air spaces and interstitial areas of the …
accumulation of protein-rich pulmonary edema in the air spaces and interstitial areas of the …